http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0734258-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb00d5aabafb773693f4f95cc11c8b71 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-609 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 |
| filingDate | 1993-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acfdba261144263f7319d8f4672ed59d |
| publicationDate | 1996-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0734258-A1 |
| titleOfInvention | Anthelmintic composition containing rafoxanide and fenbendazole |
| abstract | An anthelmintic composition for oral administration comprises an amount of rafoxanide, suitably 1.5-15 % w/v, in admixture with an amount of fenbendazole, suitably 1.0-10 % w/v, effective to achieve an elevated plasma level of an active sulphur oxide metabolite of fenbendazole following administration to bovines, caprines and ovines, relative to fenbendazole when administered alone. The active ingredients are preferably micronised with greater than 98 % of the particles having an average particle size less then 20 νm. The anthelmintic efficacy of the fenbendazole is potentiated in the presence of rafoxanide without significantly increasing any toxic sequelae. |
| priorityDate | 1993-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.